These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16542209)

  • 41. [Alendronate].
    Okazaki R
    Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
    Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
    An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
    Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
    Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
    N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bone density measurements after alendronate therapy?].
    Schoppmeyer M
    Med Monatsschr Pharm; 2015 May; 38(5):196-7; discussion 197. PubMed ID: 26364412
    [No Abstract]   [Full Text] [Related]  

  • 47. [Progress for patients with osteoporosis].
    MMW Fortschr Med; 2006 May; 148(20):56-7. PubMed ID: 16805195
    [No Abstract]   [Full Text] [Related]  

  • 48. [Osteoporosis treatment evaluation with desoxypiridinoline urine detection in postmenopause patients].
    Solís-Cabrera BH; Del Carmen Ramírez-Benítez M; Cocotle-Ronzón Y; Moreno-Todd M; Soto-Cid AH
    Rev Med Inst Mex Seguro Soc; 2009; 47(1):25-8. PubMed ID: 19624960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alendronate prevents further bone loss in renal transplant recipients.
    Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 52. Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate.
    Schneider JP
    Geriatrics; 2006 Jan; 61(1):31-3. PubMed ID: 16405362
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
    Rozenberg S; Lanoy E; Bentata M; Viard JP; Valantin MA; Missy P; Darasteanu I; Roux C; Kolta S; Costagliola D;
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):972-80. PubMed ID: 22353022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized controlled trial of alendronate in airways disease and low bone mineral density.
    Smith BJ; Laslett LL; Pile KD; Phillips PJ; Phillipov G; Evans SM; Esterman AJ; Berry JG
    Chron Respir Dis; 2004; 1(3):131-7. PubMed ID: 16281654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats.
    Nakamura Y; Hayashi K; Abu-Ali S; Naito M; Fotovati A
    J Bone Joint Surg Am; 2008 Apr; 90(4):824-32. PubMed ID: 18381321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

  • 58. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
    Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS
    Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying multiple reports from the same study.
    Lin T; Yan SG; Wang C; Cai XZ
    Orthopedics; 2011 Nov; 34(11):837-8; author reply 838. PubMed ID: 22050247
    [No Abstract]   [Full Text] [Related]  

  • 60. The Large Pharmaceutical Company Perspective.
    Rosenblatt M
    N Engl J Med; 2017 Jan; 376(1):52-60. PubMed ID: 28052221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.